1. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer. (November 2017) Authors: Soria, Jean-Charles; Adjei, Alex A.; Bahleda, Rastilav; Besse, Benjamin; Ferte, Charles; Planchard, David; Zhou, Jing; Ware, Joseph; Morrissey, Kari; Shankar, Geetha; Lin, Wei; Schutzman, Jennifer L.; Dy, Grace K.; Groen, Harry J.M. Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. (February 2019) Authors: Ma, Wen Wee; Xie, Hao; Fetterly, Gerald; Pitzonka, Laura; Whitworth, Amy; LeVea, Charles; Wilton, John; Mantione, Krystin; Schihl, Sarah; Dy, Grace K.; Boland, Patrick; Iyer, Renuka; Tan, Wei; Brady, William; Straubinger, Robert M.; Adjei, Alex A. Journal: American journal of clinical oncology Issue: Volume 42:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. (3rd June 2018) Authors: Naqash, Abdul Rafeh; Stroud, Chipman Robert Geoffrey; Butt, Muhammad Umer; Dy, Grace K.; Hegde, Aparna; Muzaffar, Mahvish; Yang, Li V.; Hafiz, Maida; Cherry, Cynthia R.; Walker, Paul R. Journal: Acta oncologica Issue: Volume 57:Number 6(2018) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer. Issue 2 (19th December 2020) Authors: Goldman, Jonathan W.; Barve, Minal; Patel, Jyoti D.; Wozniak, Antoinette; Dowlati, Afshin; Starodub, Alexander; Owonikoko, Taofeek K.; Edenfield, William; Laurie, Scott A.; Da Costa, Daniel; Lally, Satwant; Koch, Martina; Kosloski, Matthew P.; Hoffman, David; Dy, Grace K. Journal: Clinical and translational science Issue: Volume 14:Issue 2(2021) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer. Issue 1 (3rd September 2021) Authors: Ramalingam, Suresh S.; Thara, Eddie; Awad, Mark M.; Dowlati, Afshin; Haque, Basir; Stinchcombe, Thomas E.; Dy, Grace K.; Spigel, David R.; Lu, Sharon; Iyer Singh, Nithya; Tang, Yongqiang; Teslenko, Iryna; Iannotti, Nicholas Journal: Cancer Issue: Volume 128:Issue 1(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Issue 1 (24th January 2019) Authors: Conroy, Jeffrey M.; Pabla, Sarabjot; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Wang, Yirong; Lenzo, Felicia L.; Bshara, Wiam; Khalil, Maya; Dy, Grace K.; Madden, Katherine G.; Shirai, Keisuke; Dragnev, Konstantin; Tafe, Laur... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. (September 2018) Authors: Cho, Byoung Chul; Dy, Grace K.; Govindan, Ramaswamy; Kim, Dong-Wan; Pennell, Nathan A.; Zalcman, Gerard; Besse, Benjamin; Kim, Joo-Hang; Koca, Goekben; Rajagopalan, Prabhu; Langer, Simon; Ocker, Matthias; Nogai, Hendrik; Barlesi, Fabrice Journal: Lung cancer Issue: Volume 123(2018) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor. Issue 9 (September 2015) Authors: Ghani, Sofia; Desai, Arpita; Pokharel, Saraswati; Demmy, Todd; Dy, Grace K. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 9(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor. Issue 9 (September 2015) Authors: Ghani, Sofia; Desai, Arpita; Pokharel, Saraswati; Demmy, Todd; Dy, Grace K. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 9(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Issue 1 (1st February 2019) Authors: Pabla, Sarabjot; Conroy, Jeffrey M.; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Hagen, Jacob; Giamo, Vincent; Andreas, Jonathan; Lenzo, Felicia L.; Yirong, Wang; Dy, Grace K.; Yau, Edwin; Early, Amy; Chen, Hongbin; Bshara, Wiam; Madden, Katherine G.; Shirai, K... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗